ENOVIS CORP (ENOV) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:ENOV - US1940141062 - Common Stock
30.31 USD
-0.12 (-0.39%)
30.31 USD
0 (0%)
We assign a fundamental rating of 4 out of 10 to ENOV. ENOV was compared to 188 industry peers in the Health Care Equipment & Supplies industry. ENOV has a medium profitability rating, but doesn't score so well on its financial health evaluation. ENOV is valued quite cheap, while showing a decent growth score. This is a good combination!
1. Profitability
1.1 Basic Checks
ENOV had positive earnings in the past year.
In the past year ENOV had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: ENOV reported negative net income in multiple years.
Of the past 5 years ENOV 4 years had a positive operating cash flow.
1.2 Ratios
The Return On Assets of ENOV (-30.84%) is comparable to the rest of the industry.
ENOV has a Return On Equity of -67.66%. This is comparable to the rest of the industry: ENOV outperforms 44.68% of its industry peers.
The Return On Invested Capital of ENOV (0.12%) is better than 65.43% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -30.84% | ||
| ROE | -67.66% | ||
| ROIC | 0.12% |
ROA(3y)-6.18%
ROA(5y)-3.42%
ROE(3y)-11.19%
ROE(5y)-6.16%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
ENOV has a Operating Margin of 0.25%. This is in the better half of the industry: ENOV outperforms 65.43% of its industry peers.
ENOV's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 57.19%, ENOV perfoms like the industry average, outperforming 54.79% of the companies in the same industry.
In the last couple of years the Gross Margin of ENOV has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.25% | ||
| PM (TTM) | N/A | ||
| GM | 57.19% |
OM growth 3YN/A
OM growth 5Y-43.59%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.41%
GM growth 5Y6.07%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ENOV is destroying value.
The number of shares outstanding for ENOV has been increased compared to 1 year ago.
Compared to 5 years ago, ENOV has more shares outstanding
Compared to 1 year ago, ENOV has a worse debt to assets ratio.
2.2 Solvency
ENOV has an Altman-Z score of 0.83. This is a bad value and indicates that ENOV is not financially healthy and even has some risk of bankruptcy.
ENOV has a Altman-Z score (0.83) which is in line with its industry peers.
The Debt to FCF ratio of ENOV is 59.72, which is on the high side as it means it would take ENOV, 59.72 years of fcf income to pay off all of its debts.
ENOV has a better Debt to FCF ratio (59.72) than 67.02% of its industry peers.
A Debt/Equity ratio of 0.66 indicates that ENOV is somewhat dependend on debt financing.
ENOV has a worse Debt to Equity ratio (0.66) than 65.43% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | 59.72 | ||
| Altman-Z | 0.83 |
ROIC/WACC0.02
WACC7.25%
2.3 Liquidity
ENOV has a Current Ratio of 2.22. This indicates that ENOV is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of ENOV (2.22) is worse than 60.11% of its industry peers.
A Quick Ratio of 1.16 indicates that ENOV should not have too much problems paying its short term obligations.
ENOV has a Quick ratio of 1.16. This is in the lower half of the industry: ENOV underperforms 71.28% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.22 | ||
| Quick Ratio | 1.16 |
3. Growth
3.1 Past
ENOV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 26.14%, which is quite impressive.
ENOV shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -16.18% yearly.
ENOV shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.57%.
The Revenue has been decreasing by -8.73% on average over the past years.
EPS 1Y (TTM)26.14%
EPS 3Y-23.78%
EPS 5Y-16.18%
EPS Q2Q%2.74%
Revenue 1Y (TTM)11.57%
Revenue growth 3Y13.9%
Revenue growth 5Y-8.73%
Sales Q2Q%8.65%
3.2 Future
ENOV is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 23.19% yearly.
The Revenue is expected to grow by 8.87% on average over the next years. This is quite good.
EPS Next Y12.58%
EPS Next 2Y12.38%
EPS Next 3Y13.12%
EPS Next 5Y23.19%
Revenue Next Year7.28%
Revenue Next 2Y6.83%
Revenue Next 3Y6.79%
Revenue Next 5Y8.87%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 9.10, the valuation of ENOV can be described as very reasonable.
Based on the Price/Earnings ratio, ENOV is valued cheaply inside the industry as 95.21% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 26.15, ENOV is valued rather cheaply.
The Price/Forward Earnings ratio is 8.48, which indicates a very decent valuation of ENOV.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ENOV indicates a rather cheap valuation: ENOV is cheaper than 96.28% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 36.12. ENOV is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.1 | ||
| Fwd PE | 8.48 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, ENOV is valued cheaply inside the industry as 90.43% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, ENOV is valued a bit cheaper than the industry average as 70.74% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 76.1 | ||
| EV/EBITDA | 10.28 |
4.3 Compensation for Growth
ENOV's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ENOV's earnings are expected to grow with 13.12% in the coming years.
PEG (NY)0.72
PEG (5Y)N/A
EPS Next 2Y12.38%
EPS Next 3Y13.12%
5. Dividend
5.1 Amount
No dividends for ENOV!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
30.31
-0.12 (-0.39%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners121.31%
Inst Owner Change-2.39%
Ins Owners1.19%
Ins Owner Change0.71%
Market Cap1.73B
Revenue(TTM)2.23B
Net Income(TTM)-1.37B
Analysts83.75
Price Target51 (68.26%)
Short Float %13.73%
Short Ratio9.54
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.55%
Min EPS beat(2)7.76%
Max EPS beat(2)13.35%
EPS beat(4)4
Avg EPS beat(4)8.22%
Min EPS beat(4)4.97%
Max EPS beat(4)13.35%
EPS beat(8)8
Avg EPS beat(8)7.21%
EPS beat(12)12
Avg EPS beat(12)8.15%
EPS beat(16)16
Avg EPS beat(16)8.66%
Revenue beat(2)0
Avg Revenue beat(2)-0.15%
Min Revenue beat(2)-0.21%
Max Revenue beat(2)-0.09%
Revenue beat(4)0
Avg Revenue beat(4)-0.8%
Min Revenue beat(4)-1.97%
Max Revenue beat(4)-0.09%
Revenue beat(8)2
Avg Revenue beat(8)-0.81%
Revenue beat(12)4
Avg Revenue beat(12)-0.8%
Revenue beat(16)5
Avg Revenue beat(16)-4.71%
PT rev (1m)-7.98%
PT rev (3m)-7.98%
EPS NQ rev (1m)-5.34%
EPS NQ rev (3m)-5.55%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.02%
Revenue NQ rev (1m)-1.26%
Revenue NQ rev (3m)-1.34%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.1 | ||
| Fwd PE | 8.48 | ||
| P/S | 0.78 | ||
| P/FCF | 76.1 | ||
| P/OCF | 7.98 | ||
| P/B | 0.86 | ||
| P/tB | N/A | ||
| EV/EBITDA | 10.28 |
EPS(TTM)3.33
EY10.99%
EPS(NY)3.57
Fwd EY11.79%
FCF(TTM)0.4
FCFY1.31%
OCF(TTM)3.8
OCFY12.53%
SpS39.07
BVpS35.35
TBVpS-8.37
PEG (NY)0.72
PEG (5Y)N/A
Graham Number51.47
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -30.84% | ||
| ROE | -67.66% | ||
| ROCE | 0.15% | ||
| ROIC | 0.12% | ||
| ROICexc | 0.12% | ||
| ROICexgc | 0.34% | ||
| OM | 0.25% | ||
| PM (TTM) | N/A | ||
| GM | 57.19% | ||
| FCFM | 1.02% |
ROA(3y)-6.18%
ROA(5y)-3.42%
ROE(3y)-11.19%
ROE(5y)-6.16%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-45.54%
ROICexc growth 3YN/A
ROICexc growth 5Y-43.8%
OM growth 3YN/A
OM growth 5Y-43.59%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.41%
GM growth 5Y6.07%
F-Score4
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | 59.72 | ||
| Debt/EBITDA | 4.5 | ||
| Cap/Depr | 66.6% | ||
| Cap/Sales | 8.7% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 72.98% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.22 | ||
| Quick Ratio | 1.16 | ||
| Altman-Z | 0.83 |
F-Score4
WACC7.25%
ROIC/WACC0.02
Cap/Depr(3y)55.91%
Cap/Depr(5y)50.8%
Cap/Sales(3y)7.49%
Cap/Sales(5y)6.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)26.14%
EPS 3Y-23.78%
EPS 5Y-16.18%
EPS Q2Q%2.74%
EPS Next Y12.58%
EPS Next 2Y12.38%
EPS Next 3Y13.12%
EPS Next 5Y23.19%
Revenue 1Y (TTM)11.57%
Revenue growth 3Y13.9%
Revenue growth 5Y-8.73%
Sales Q2Q%8.65%
Revenue Next Year7.28%
Revenue Next 2Y6.83%
Revenue Next 3Y6.79%
Revenue Next 5Y8.87%
EBIT growth 1Y-35.24%
EBIT growth 3YN/A
EBIT growth 5Y-48.51%
EBIT Next Year74.87%
EBIT Next 3Y29.81%
EBIT Next 5Y28.11%
FCF growth 1Y122.66%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y609.06%
OCF growth 3Y-31.69%
OCF growth 5Y-2.82%
ENOVIS CORP / ENOV FAQ
What is the ChartMill fundamental rating of ENOVIS CORP (ENOV) stock?
ChartMill assigns a fundamental rating of 4 / 10 to ENOV.
Can you provide the valuation status for ENOVIS CORP?
ChartMill assigns a valuation rating of 8 / 10 to ENOVIS CORP (ENOV). This can be considered as Undervalued.
Can you provide the profitability details for ENOVIS CORP?
ENOVIS CORP (ENOV) has a profitability rating of 4 / 10.
What is the earnings growth outlook for ENOVIS CORP?
The Earnings per Share (EPS) of ENOVIS CORP (ENOV) is expected to grow by 12.58% in the next year.